{"url_path":"/sec/ixhl/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-057227-index.html","accession_number":"0001213900-26-057227","cik":"0001873875","ticker":"IXHL","issuer_name":"Incannex Healthcare Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1873875/0001213900-26-057227-index.html","primary_entity_key":"0001873875","primary_entity_name":"Incannex Healthcare Inc."},"word_count":220,"has_tables":true,"body_markdown":"Item\n2. Unregistered Sales of Equity Securities and Use of Proceeds\n\n** **\n\n**Issuer\nPurchases of Equity Securities**\n\n \n\nThe\nnumber of shares of Common Stock repurchased by us under our share repurchase program and the average price paid per share for the three\nmonths ended March 31, 2026, are as follows:\n\n \n\n**Period**\n \n**(a) Total\nNumber of\nShares\nRepurchased**\n \n \n**(b) Average\nPrice Paid Per\nShare**\n \n \n**(c) Total\nNumber of\nShares\nRepurchased as\nPart of Publicly\nAnnounced\nPlans or\nPrograms**\n \n \n**(d) Maximum\nDollar Value of\nShares that\nMay Yet Be\nRepurchased\nUnder the Plans\nor Programs**\n \n\nJanuary 2026 (1/1/2026 - 1/31/2026)\n \n \n29,650\n \n \n \n9.69\n \n \n \n29,650\n \n \n \n18,536,817\n \n\nFebruary 2026 (2/1/2026 - 2/28/2026)\n \n \n-\n \n \n \n-\n \n \n \n-\n \n \n \n18,536,817\n \n\nMarch 2026 (3/1/2026 - 3/31/2026)\n \n \n260,911\n \n \n \n3.28\n \n \n \n260,911\n \n \n \n17,681,029\n \n\nTotal(1)\n \n \n290,561\n \n \n \n \n \n \n \n290,561\n \n \n \n17,681,029\n \n\n \n\n(1)\nIn\nAugust 2025, our board of directors authorized a share repurchase program pursuant to which\nwe may repurchase up to $20 million of our outstanding shares of Common Stock. The share\nrepurchase program expires on August 30, 2026. Under the share repurchase program, the\nCompany may repurchase shares from time to time in the open market, privately negotiated\ntransactions, accelerated share repurchase arrangements, or other methods permitted under\napplicable securities laws, including in compliance with Rule 10b-18 of the Exchange Act.\nAll purchases listed above were made in the open market at prevailing market prices.\n\n \n\n27"}